Lamba Sanjiv 4

Accession 0001707925-25-000047

CIK 0001707925other

View on SEC.gov Company Profile

Filed

Mar 10, 8:00 PM ET

Accepted

Mar 11, 8:01 PM ET

Size

40.9 KB

Accession

0001707925-25-000047

Insider Transaction Report

Form 4

Period: 2025-03-07

LINDE PLCLIN

Lamba Sanjiv

DirectorChief Executive Officer

Transactions

Exercise/Conversion
Ordinary Shares
2025-03-10+6,335→ 74,610.95 total
Tax Payment
Ordinary Shares
2025-03-10$468.77/sh−2,786.767$1,306,353→ 71,824.183 total
Exercise/Conversion
Performance Share Units (ROC)
2025-03-10−19,000→ 0 total
Exercise: $0.00→ Ordinary Shares (19,000 underlying)
Award
Stock Options (right to buy)
2025-03-07+44,696→ 44,696 total
Exercise: $468.77Exp: 2035-03-07→ Ordinary Shares (44,696 underlying)
Tax Payment
Ordinary Shares
2025-03-10$468.77/sh−8,804.601$4,127,333→ 82,019.582 total
Tax Payment
Ordinary Shares
2025-03-10$468.77/sh−5,401.391$2,532,010→ 88,274.191 total
Award
Performance Share Units (ROC)
2025-03-10+19,000→ 19,000 total
Exercise: $0.00→ Ordinary Shares (19,000 underlying)
Exercise/Conversion
Ordinary Shares
2025-03-10+19,000→ 90,824.183 total
Exercise/Conversion
Ordinary Shares
2025-03-10+11,656→ 93,675.582 total
Exercise/Conversion
Performance Share Units (RTSR)
2025-03-10−11,656→ 0 total
Exercise: $0.00→ Ordinary Shares (11,656 underlying)
Exercise/Conversion
Restricted Stock Units
2025-03-10−6,335→ 0 total
→ Ordinary Shares (6,335 underlying)
Award
Performance Share Units (RTSR)
2025-03-10+11,656→ 11,656 total
Exercise: $0.00→ Ordinary Shares (11,656 underlying)
Award
Restricted Stock Units
2025-03-07+6,364→ 6,364 total
Exercise: $0.00→ Ordinary Shares (6,364 underlying)

Holdings

Restricted Stock Units
→ Ordinary Shares (6,405 underlying)
6,405
Stock Options (right to buy)
Exercise: $465.29Exp: 2034-03-07→ Ordinary Shares (41,530 underlying)
41,530
Stock Options (right to buy)
Exercise: $173.13Exp: 2030-03-09→ Ordinary Shares (37,565 underlying)
37,565
Stock Options (right to buy)
Exercise: $176.63Exp: 2029-03-20→ Ordinary Shares (15,470 underlying)
15,470
Restricted Stock Units
→ Ordinary Shares (7,015 underlying)
7,015
Stock Options (right to buy)
Exercise: $354.14Exp: 2033-03-07→ Ordinary Shares (46,365 underlying)
46,365
Stock Options (right to buy)
Exercise: $270.99Exp: 2032-03-07→ Ordinary Shares (54,920 underlying)
54,920
Stock Options (right to buy)
Exercise: $253.68Exp: 2031-03-08→ Ordinary Shares (40,995 underlying)
40,995
Deferred Stock Units
Exercise: $0.00→ Ordinary Shares (406.322 underlying)
406.322

Footnotes (18)

[F1]Ordinary shares acquired pursuant to the payout of a restricted stock unit grant made on March 7, 2022.
[F10]Restricted Stock Units that will vest in full and payout on or about March 7, 2026 in Linde plc Ordinary Shares on a one-for-one basis.
[F11]This option vests over three years in three consecutive equal annual installments beginning on March 7, 2026.
[F12]This option vests over three years in three consecutive equal annual installments beginning on March 7, 2025.
[F13]This option vests over three years in three consecutive equal annual installments beginning on March 7, 2024.
[F14]This option vests over three years in three consecutive equal annual installments beginning on March 7, 2023.
[F15]This option vests over three years in three consecutive equal annual installments beginning on March 8, 2022.
[F16]Stock options have been granted pursuant to the Business Combination Agreement among Praxair, Inc., Linde AG, Linde plc and certain of their affiliates, dated June 1, 2017, as amended (the "BCA"). The stock options replace certain previously granted equity awards granted by Linde AG that were terminated in connection with the closing of the Business Combination of Praxair, Inc. and Linde AG that occurred on October 31, 2018. A more detailed explanation of these stock option replacement awards is discussed in the Linde plc Registration Statement on Form S-4 (Amendment No. 4) filed with the SEC on August 11, 2017 under the section titled "The Business Combination - Interests of Directors, Board Members and Executive Officers in the Business Combination - Linde AG - Treatment of Equity Awards" on pages 183-187.
[F17]This option vests over three years in three consecutive equal annual installments beginning March 20, 2020.
[F18]Deferred Stock Units acquired under the Linde Compensation Deferral Plan that will payout in Linde plc Ordinary Shares on a one-for-one basis in accordance with the Deferral Plan.
[F2]Ordinary shares withheld from the payout to cover tax withholdings.
[F3]Ordinary shares acquired pursuant to the payout of a performance share unit ("PSU") grant made on March 7, 2022.
[F4]The PSU paid out on March 10, 2025 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Linde plc from 2022-2025 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted on March 7, 2022.
[F5]The PSU paid out on March 10, 2025 and the number of shares awarded and paid out was determined based upon the total shareholder return ("TSR") of Linde plc from 2022-2025 measured against TSR goals set by the Human Capital Committee of the Board of Directors when the PSU was granted on March 7, 2022.
[F6]Conversion to Linde plc Ordinary Shares is on a 1-for-1 basis.
[F7]Restricted Stock Units that will vest in full and payout on or about March 7, 2025 in Linde plc Ordinary Shares on a one-for-one basis
[F8]Restricted Stock Units that will vest in full and payout on or about March 7, 2028 in Linde plc Ordinary Shares on a one-for-one basis.
[F9]Restricted Stock Units that will vest in full and payout on or about March 7, 2027 in Linde plc Ordinary Shares on a one-for-one basis.

Documents

1 file

4
wk-form4_1741737685.xmlPrimary
FORM 4

Issuer

LINDE PLC

CIK 0001707925

→

Entity typeother

Related Parties

filerCIK 0001757274

Filing Metadata

Form type: 4
Filed: Mar 10, 8:00 PM ET
Accepted: Mar 11, 8:01 PM ET
Size: 40.9 KB

View on SEC.gov